201 related articles for article (PubMed ID: 17635146)
1. Cell-penetrating-peptide-based delivery of oligonucleotides: an overview.
Abes R; Arzumanov AA; Moulton HM; Abes S; Ivanova GD; Iversen PL; Gait MJ; Lebleu B
Biochem Soc Trans; 2007 Aug; 35(Pt 4):775-9. PubMed ID: 17635146
[TBL] [Abstract][Full Text] [Related]
2. Peptide-based delivery of nucleic acids: design, mechanism of uptake and applications to splice-correcting oligonucleotides.
Abes S; Moulton H; Turner J; Clair P; Richard JP; Iversen P; Gait MJ; Lebleu B
Biochem Soc Trans; 2007 Feb; 35(Pt 1):53-5. PubMed ID: 17233600
[TBL] [Abstract][Full Text] [Related]
3. Vectorization of morpholino oligomers by the (R-Ahx-R)4 peptide allows efficient splicing correction in the absence of endosomolytic agents.
Abes S; Moulton HM; Clair P; Prevot P; Youngblood DS; Wu RP; Iversen PL; Lebleu B
J Control Release; 2006 Dec; 116(3):304-13. PubMed ID: 17097177
[TBL] [Abstract][Full Text] [Related]
4. Cell penetrating peptide conjugates of steric block oligonucleotides.
Lebleu B; Moulton HM; Abes R; Ivanova GD; Abes S; Stein DA; Iversen PL; Arzumanov AA; Gait MJ
Adv Drug Deliv Rev; 2008 Mar; 60(4-5):517-29. PubMed ID: 18037527
[TBL] [Abstract][Full Text] [Related]
5. Arginine-rich cell penetrating peptides: design, structure-activity, and applications to alter pre-mRNA splicing by steric-block oligonucleotides.
Abes R; Arzumanov A; Moulton H; Abes S; Ivanova G; Gait MJ; Iversen P; Lebleu B
J Pept Sci; 2008 Apr; 14(4):455-60. PubMed ID: 18236382
[TBL] [Abstract][Full Text] [Related]
6. Delivery of steric block morpholino oligomers by (R-X-R)4 peptides: structure-activity studies.
Abes R; Moulton HM; Clair P; Yang ST; Abes S; Melikov K; Prevot P; Youngblood DS; Iversen PL; Chernomordik LV; Lebleu B
Nucleic Acids Res; 2008 Nov; 36(20):6343-54. PubMed ID: 18796528
[TBL] [Abstract][Full Text] [Related]
7. Lipoplex and peptide-based strategies for the delivery of steric-block oligonucleotides.
Resina S; Abes S; Turner JJ; Prevot P; Travo A; Clair P; Gait MJ; Thierry AR; Lebleu B
Int J Pharm; 2007 Nov; 344(1-2):96-102. PubMed ID: 17600642
[TBL] [Abstract][Full Text] [Related]
8. Cell-penetrating peptide-morpholino conjugates alter pre-mRNA splicing of DMD (Duchenne muscular dystrophy) and inhibit murine coronavirus replication in vivo.
Moulton HM; Fletcher S; Neuman BW; McClorey G; Stein DA; Abes S; Wilton SD; Buchmeier MJ; Lebleu B; Iversen PL
Biochem Soc Trans; 2007 Aug; 35(Pt 4):826-8. PubMed ID: 17635157
[TBL] [Abstract][Full Text] [Related]
9. Efficient splicing correction by PNA conjugation to an R6-Penetratin delivery peptide.
Abes S; Turner JJ; Ivanova GD; Owen D; Williams D; Arzumanov A; Clair P; Gait MJ; Lebleu B
Nucleic Acids Res; 2007; 35(13):4495-502. PubMed ID: 17584792
[TBL] [Abstract][Full Text] [Related]
10. Stability of cell-penetrating peptide-morpholino oligomer conjugates in human serum and in cells.
Youngblood DS; Hatlevig SA; Hassinger JN; Iversen PL; Moulton HM
Bioconjug Chem; 2007; 18(1):50-60. PubMed ID: 17226957
[TBL] [Abstract][Full Text] [Related]
11. Induction of splice correction by cell-penetrating peptide nucleic acids.
El-Andaloussi S; Johansson HJ; Lundberg P; Langel U
J Gene Med; 2006 Oct; 8(10):1262-73. PubMed ID: 16900561
[TBL] [Abstract][Full Text] [Related]
12. Arginine-rich peptides and their internalization mechanisms.
Futaki S; Nakase I; Tadokoro A; Takeuchi T; Jones AT
Biochem Soc Trans; 2007 Aug; 35(Pt 4):784-7. PubMed ID: 17635148
[TBL] [Abstract][Full Text] [Related]
13. Cell penetration: scope and limitations by the application of cell-penetrating peptides.
Reissmann S
J Pept Sci; 2014 Oct; 20(10):760-84. PubMed ID: 25112216
[TBL] [Abstract][Full Text] [Related]
14. Helix-Stabilized Cell-Penetrating Peptides for Delivery of Antisense Morpholino Oligomers: Relationships among Helicity, Cellular Uptake, and Antisense Activity.
Takada H; Tsuchiya K; Demizu Y
Bioconjug Chem; 2022 Jul; 33(7):1311-1318. PubMed ID: 35737901
[TBL] [Abstract][Full Text] [Related]
15. Efficient intracellular delivery of nucleic acid pharmaceuticals using cell-penetrating peptides.
Nakase I; Akita H; Kogure K; Gräslund A; Langel U; Harashima H; Futaki S
Acc Chem Res; 2012 Jul; 45(7):1132-9. PubMed ID: 22208383
[TBL] [Abstract][Full Text] [Related]
16. Peptide-based delivery of steric-block PNA oligonucleotides.
Abes S; Ivanova GD; Abes R; Arzumanov AA; Williams D; Owen D; Lebleu B; Gait MJ
Methods Mol Biol; 2009; 480():85-99. PubMed ID: 19085117
[TBL] [Abstract][Full Text] [Related]
17. Cell-penetrating-peptide-mediated siRNA lung delivery.
Moschos SA; Williams AE; Lindsay MA
Biochem Soc Trans; 2007 Aug; 35(Pt 4):807-10. PubMed ID: 17635153
[TBL] [Abstract][Full Text] [Related]
18. Recent developments in peptide-based nucleic acid delivery.
Veldhoen S; Laufer SD; Restle T
Int J Mol Sci; 2008 Jun; 9(7):1276-1320. PubMed ID: 19325804
[TBL] [Abstract][Full Text] [Related]
19. Peptide vectors for the nonviral delivery of nucleic acids.
Hoyer J; Neundorf I
Acc Chem Res; 2012 Jul; 45(7):1048-56. PubMed ID: 22455499
[TBL] [Abstract][Full Text] [Related]
20. The many futures for cell-penetrating peptides: how soon is now?
Howl J; Nicholl ID; Jones S
Biochem Soc Trans; 2007 Aug; 35(Pt 4):767-9. PubMed ID: 17635144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
